Cantarovich, D <br/><br/>
Prophylactic use of a monoclonal antibody (33B3.1) directed against interleukin 2 receptor following human renal transplantation.  [electronic resource] 

 -  American journal of kidney diseases : the official journal of the National Kidney Foundation  Feb 1988 
 - 101-6 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>0272-6386 
<br/><br/><label>Standard No.: </label>10.1016/s0272-6386(88)80189-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Monoclonal--adverse effects<br/>Cadaver<br/>Drug Evaluation<br/>Drug Tolerance<br/>Graft Rejection--drug effects<br/>Humans<br/>Immunoglobulin G--analysis<br/>Immunoglobulin M--analysis<br/>Immunosuppression Therapy--methods<br/>Interleukin-2--immunology<br/>Kidney Failure, Chronic--immunology<br/>Kidney Transplantation<br/>Rats<br/>Receptors, Immunologic--immunology<br/>Receptors, Interleukin-2<br/>Time Factors